SQSTM1 and rhabdomyosarcoma: Furthermore, in vitro and in vivo passive immunization models with immunoglobulin G extracted from anti-cN1A–seropositive IBM patient serum samples have been found to exhibit higher p62/SQSTM1 expression and abundant aggregations in the cytoplasm of supplemented rhabdomyosarcoma cells.